Ignite Creation Date:
2024-05-06 @ 10:57 AM
Last Modification Date:
2024-10-26 @ 12:38 PM
Study NCT ID:
NCT03395080
Status:
COMPLETED
Last Update Posted:
2023-07-12
First Post:
2018-01-02
Brief Title:
A Study of DKN-01 as a Monotherapy or in Combination With Paclitaxel in Patients With Recurrent Epithelial Endometrial or Epithelial Ovarian Cancer or Carcinosarcoma
Sponsor:
Leap Therapeutics Inc
Organization:
Leap Therapeutics Inc
Organization Data
Organization:
Leap Therapeutics Inc
Class:
INDUSTRY
Study ID:
DEK-DKK1-P204
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Leap Therapeutics Inc
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None